Oncolytics Biotech (ONCY) Interest Coverage Ratio (2019 - 2025)

Oncolytics Biotech (ONCY) has 7 years of Interest Coverage Ratio data on file, last reported at 443.0 in Q3 2025.

• On a quarterly basis, Interest Coverage Ratio fell 96.08% year-over-year to 443.0 in Q3 2025; TTM through Sep 2025 was 267.23, a 202.31% decrease from a year earlier, with the FY2025 full-year figure at 0.72, down 1.45% from the prior year.
• Interest Coverage Ratio for Q3 2025 stood at 443.0, down from 190.06 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for ONCY reached as high as 299.34 in Q2 2021 and fell as low as 1714.46 in Q4 2021.
• Historically, Interest Coverage Ratio has averaged 177.9 across 5 years, with a median of 190.06 in 2025.
• Across the five-year window, Interest Coverage Ratio jumped 164.03% in 2021 and slumped 268.91% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 1714.46 in 2021, then soared by 117.01% to 291.69 in 2022, then plunged by 172.89% to 212.61 in 2023, then rose by 6.47% to 198.85 in 2024, then tumbled by 122.78% to 443.0 in 2025.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 443.0 in Q3 2025, 190.06 in Q2 2025, and 198.85 in Q4 2024.